PHIA Koninklijke Philips N.V.

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

May 30, 2024

First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico

Amsterdam, the Netherlands and Bayamón, Puerto Rico (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico’s Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustainability benefits [2], helium-free MRI operations also increase resilience in the face of the tropical storms that hit Puerto Rico every year delivering quality care to patients who may otherwise not have access to advanced MRI scanning.

“The installation of our Philips MR 5300 scanner, with a 70cm bore and equipped with the 1,111th BlueSeal magnet at Vida Imaging & Breast Center in Puerto Rico is a testament to the global adoption of our innovative technology. Since 2018, Philips has been the first to provide helium-free MR operations worldwide, improving access to better care for more patients, and we will continue to drive innovation in this space,” said Ruud Zwerink, Business Leader of MR at Philips. “BlueSeal magnet technology has proven to be the system of choice for improved diagnostic capabilities, while providing an answer to , saving approximately 1.9 million liters of liquid helium to date.”

A BlueSeal magnet’s ability to be shut down and re-energized in a controlled way, without the loss of its liquid helium coolant, means it can be up and running precisely when it is needed to treat patients. The Vida Imaging & Breast Center, which provides a wide range of medical imaging services, is a vital community asset that helps patients on the remote island of Puerto Rico receive high-quality healthcare.

“Puerto Rico has tropical storms every year. Philips BlueSeal magnet technology allows us to de-energize our MRI system to prepare the MRI department for this situation and restore operations quickly once it is safe, all from the MRI console,” said Dr. Mayra Maldonado, Owner/CEO at the Vida Imaging & Breast Center.

In the aftermath of a hurricane or other natural disaster, transport systems are disrupted, and obtaining helium, especially when transporting to remote locations, could take weeks. A conventional MRI scanner requires up to 1700 liters of liquid helium, much of which can be lost if the magnet has to be periodically shut down. A Philips BlueSeal magnet only requires a pre-load of 7 liters during manufacturing and loses none of it, even during a so-called magnet quench – a sudden loss of superconductivity in the magnet coil which rapidly boils the liquid helium. Philips’ AI-enabled [3] EasySwitch technology always ensures orderly shutdown and re-energizing of the magnet once the danger has passed.

With a magnet that is 900kg lighter than a traditional system [4], Philips MR systems equipped with BlueSeal magnets can also be installed in places that were previously unthinkable like elevated floors or indoor sites with construction limitations. This technology is even available in [5] that have the potential to expand quality access to MRI exams for patients in a more sustainable [2] way.

[1] Systems contain 7 liters of helium, fully sealed, no helium can leave the system.

[2] Compared to the Ingenia 1.5T ZBO magnet.

[3] According to the definition of the EU High-Level Expert Group on Artificial Intelligence.

[4] Compared to Philips earlier (non-BlueSeal) Ingenia 1.5T ZBO magnet.

[5] BlueSeal MR mobile unit 1.5T is considered a work in progress. It is not CE marked and not available for sale outside of the U.S.

For further information, please contact:





Kathy O’Reilly

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
30/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips announces collaboration with Epic to enhance ambulatory cardia...

Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform CAMBRIDGE, Mass. – (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with to integrate Philips’ suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company. This collaboration will offer the broadest cardiac care portfolio of any single service provider integrating...

 PRESS RELEASE

Philips advances minimally invasive therapy procedures in prostate can...

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with the FDA 510(k) clearance of the latest . The system includes a new advanced annotation [1] workflow that supports clinicians during focal thera...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASM International: 2Q25 Results; Positive tone, weak orders. CM.com: 1H25 results; disappointing performance, guidance downgrade. Gimv: Gimv fuels Hemink's sustainable expansion. KPN: Solid 2Q25, guidance raised largely on €25m IPR claim benefit. Philips: 2Q25 Preview; improvement needed. Randstad: 2Q25 in line; outlook touch below; FX spoils the party but operational leverage story is unfolding. Sofina: Newsletter #16. Universal Music Group: EU opens in-depth investigation into Downtown ...

 PRESS RELEASE

Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis

Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis July 17, 2025 Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem CAMBRIDGE, Mass. — (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to multiple vendor offerings all in one central location to help clinicians manage and implement AI-powered diagnostic tools more easily. , an AI-driven health technology company committed to tran...

 PRESS RELEASE

Philips Foundation 2024 Annual Report: expanding access to quality hea...

Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people In 2024, Philips Foundation initiated 22 new projects and 5 new impact investments expanding its impact and reach in innovative healthcare delivery to India and South AmericaCelebrating a decade of impact with strong progress towards the Foundation’s 2030 goal to improve access to healthcare for 100 million people in underserved communities a yearThe combined impact of longstanding strategic collaborations and new innovative partnerships with healthcare ventures affirm the Foundation’s appr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch